Join to View Full Profile
5758 S. Maryland Ave.Chicago, IL 60637
Dr. Juloori is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Radiation Oncology, 2014 - 2019
Baylor College of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2019 - 2026
IN State Medical License 2024 - 2025
OH State Medical License 2014 - 2019
American Board of Radiology Radiation Oncology
Clinical Trials
- GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 Start of enrollment: 2022 Nov 17
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours Start of enrollment: 2024 Jul 31
- Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) Start of enrollment: 2022 Aug 19
Publications & Presentations
PubMed
- Patient-specific modeling of radiation-induced lymphopenia for head and neck cancer.Jiaxin Li, Rahul Mali, Gregory N Gan, Christopher Lominska, Kenny Guida
Medical Physics. 2025-04-14 - 1 citationsAnalysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.Hanna M Hieromnimon, Anna Trzcinska, Frank T Wen, Frederick M Howard, James M Dolezal
Oral Oncology. 2025-04-01 - Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer.Rajat Thawani, Christine M Bestvina, Everett E Vokes, Aditya Juloori
Journal of Clinical Oncology. 2025-03-27
Journal Articles
- Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and ToxicityBrian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
Press Mentions
Targeted Therapies + SRS Combo Prolongs Survival in Patients with Renal Cell Carcinoma Brain MetastasesSeptember 27th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
